Filing Flows › BioMarin Pharmaceutical (BMRN) › Net product revenues revenue
BioMarin Pharmaceutical (BMRN) Net product revenues revenue by quarter
BioMarin Pharmaceutical's Net product revenues revenue was $1.0B in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $735M (Q1 2025) to $1.0B (Q3 2026).
| Quarter | Net product revenues revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.0B | +3% | +33% |
| Q2 2026 | $984M | +30% | +21% |
| Q1 2026 | $757M | -12% | +3% |
| Q4 2025 | $862M | +13% | — |
| Q3 2025 | $761M | -7% | — |
| Q2 2025 | $816M | +11% | — |
| Q1 2025 | $735M | — | — |
Q3 2026 at a glance
BioMarin Pharmaceutical, Q3 2026: revenue $1.0B (+32% year over year), operating margin -8.0%, net loss $123M, operating cash flow $188M. The chart follows the revenue to costs, profit and cash.
Questions
What is BioMarin Pharmaceutical's Net product revenues revenue?
BioMarin Pharmaceutical's Net product revenues revenue was $1.0B in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has BioMarin Pharmaceutical's Net product revenues revenue changed?
Over the last 7 quarters it ranged from $735M (Q1 2025) to $1.0B (Q3 2026).
Q3 2026 results → · How BioMarin Pharmaceutical makes money →